# Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections

> **NCT00621192** · PHASE1,PHASE2 · COMPLETED · sponsor: **The Emmes Company, LLC** · enrollment: 200 (actual)

## Conditions studied

- Necrotizing Enterocolitis
- Intra-abdominal Infection

## Interventions

- **DRUG:** meropenem

## Key facts

- **NCT ID:** NCT00621192
- **Lead sponsor:** The Emmes Company, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2023-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00621192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00621192, "Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00621192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*